Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Price : 0.791 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 0.7919 | 0.82 | 0.78 | 0.80 | 492495.0 |
| Sep 17, 2026 | 0.7154 | 0.7897 | 0.7025 | 0.7892 | 262696.0 |
| Sep 16, 2026 | 0.7101 | 0.74 | 0.70 | 0.7021 | 266509.0 |
| Sep 15, 2026 | 0.7843 | 0.79 | 0.7001 | 0.7075 | 556131.0 |
| Sep 14, 2026 | 0.8007 | 0.8454 | 0.75 | 0.791 | 346824.0 |
| Sep 11, 2026 | 0.7993 | 0.8132 | 0.7702 | 0.785 | 295565.0 |
| Sep 10, 2026 | 0.82 | 0.835 | 0.7716 | 0.7809 | 240772.0 |
| Sep 09, 2026 | 0.88 | 0.88 | 0.8221 | 0.8275 | 265270.0 |
| Sep 08, 2026 | 0.93 | 0.9598 | 0.85 | 0.8625 | 763813.0 |
| Sep 04, 2026 | 0.92 | 0.92 | 0.85 | 0.8891 | 986045.0 |
| Sep 03, 2026 | 0.79 | 0.8700 | 0.79 | 0.8436 | 568107.0 |
| Sep 02, 2026 | 0.76 | 0.791 | 0.7363 | 0.7748 | 489076.0 |
| Sep 01, 2026 | 0.749 | 0.765 | 0.7293 | 0.7527 | 344263.0 |
| Aug 31, 2026 | 0.77 | 0.7762 | 0.7407 | 0.7499 | 546084.0 |
| Aug 28, 2026 | 0.7884 | 0.7884 | 0.7621 | 0.7621 | 259034.0 |
| Aug 27, 2026 | 0.7923 | 0.8112 | 0.7825 | 0.7828 | 136466.0 |
| Aug 26, 2026 | 0.81 | 0.8241 | 0.78 | 0.80 | 324711.0 |
| Aug 25, 2026 | 0.8044 | 0.822 | 0.7706 | 0.80 | 276754.0 |
| Aug 24, 2026 | 0.82 | 0.8241 | 0.77 | 0.80 | 463562.0 |
| Aug 21, 2026 | 0.80 | 0.855 | 0.7706 | 0.818 | 583528.0 |
| Aug 20, 2026 | 0.8563 | 0.8765 | 0.775 | 0.7936 | 2.489M |
| Aug 19, 2026 | 0.80 | 0.8186 | 0.7704 | 0.792 | 352895.0 |
| Aug 18, 2026 | 0.8492 | 0.8774 | 0.77 | 0.7701 | 525301.0 |
| Aug 17, 2026 | 0.82 | 0.8599 | 0.7754 | 0.8413 | 296666.0 |
| Aug 14, 2026 | 0.81 | 0.8171 | 0.7601 | 0.806 | 216067.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.40 |
| Alnylam Pharmaceuticals, Inc. | 244.24 |
| Anika Therapeutics, Inc. | 20.72 |
| Savara, Inc. | 5.455 |
| Vericel Corp. | 39.53 |
Price Related Metrics
| Price to Book Value | 6.652 |
| Earnings Yield | -217.2% |
| Market Cap | 67.84M |